Anti-Serotonin transporter (phospho T276) antibody
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Polyclonal Serotonin transporter phospho T276 antibody. Suitable for WB and reacts with Rat samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Rat Slc6a4 phospho T276.
View Alternative Names
Sodium-dependent serotonin transporter, SERT, 5HT transporter, Solute carrier family 6 member 4, 5HTT, Slc6a4
- WB
Supplier Data
Western blot - Anti-Serotonin transporter (phospho T276) antibody (AB194262)
All lanes:
Western blot - Anti-Serotonin transporter (phospho T276) antibody (ab194262) at 1/1000 dilution
Lane 1:
Rat mid brain membrane lysate
Lane 2:
Rat mid brain membrane lysate with immunizing peptide
Predicted band size: 70 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of SERT impacts neurotransmitter balance significantly as it is integral to serotonin regulation. By removing serotonin from the synaptic cleft and recycling it SERT maintains neurotransmitter homeostasis. SERT is not usually part of a larger protein complex but acts independently to modulate serotonin levels. The activity of SERT affects various neurological processes contributing to mood maintenance and behavioral controls.
Pathways
Serotonin transporter influences the serotonin signaling pathway which is important for mood regulation and cognitive functions. It works alongside other proteins like monoamine oxidase which degrades serotonin and serotonin receptors that mediate its effects. Additionally SERT is involved in the pharmacological pathways of antidepressants. Escitalopram oxalate and other selective serotonin reuptake inhibitors (SSRIs) target SERT to block the reuptake of serotonin increasing its extracellular levels and synaptic availability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 44:13 PubMed39810240
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com